Trial Profile
Exploratory Phase II Clinical Trial to Evaluate the Efficacy and Safety of Clotinab (Abciximab) in Acute Myocardial Infarction Patients: Multicenter, Randomized, Double Blind, Placebo-controlled and Parallel Group Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2018
Price :
$35
*
At a glance
- Drugs Abciximab (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Sponsors ISU Abxis
- 05 Apr 2017 New trial record